Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00641238 · ClinicalTrials.gov registry record
Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00641238: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT00641238 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00641238 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The research objective is to determine whether the patients with (RFA) remain alive, and whether they are in remission or have progressive/ recurrent malignancy
Interventions
- DEVICE Radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-03 |
| Est. Completion | 2011-02 |
What the finished NCT00641238 record still lists
NCT00641238 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency ablation is the first listed.
NCT00641238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00641238 about?
NCT00641238 is a clinical study titled "Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)". We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The research objective is to determine whether the patients with (RFA) remain alive, and whether they ar...
What is the current status of trial NCT00641238?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2004-03. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00641238?
The interventions under investigation include: Radiofrequency ablation (DEVICE).
Who is sponsoring clinical trial NCT00641238?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia